Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HMCN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
MAPRE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABL6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLCD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101930075 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XIRP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOVA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INSRR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLP1R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PURA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FCER2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB7C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on